Amylyx Pharmaceuticals, Inc. — Investor Relations & Filings
Amylyx Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of novel therapies for neurodegenerative diseases and other conditions with high unmet medical needs. The company's primary therapeutic candidate was AMX0035 for the treatment of amyotrophic lateral sclerosis (ALS). In April 2024, following the results of a Phase 3 clinical trial, Amylyx announced it would voluntarily withdraw the marketing authorizations for AMX0035 in the U.S. and Canada. The company is advancing a pipeline of other investigational therapies, utilizing a modality-agnostic approach to match treatments to diseases based on mechanistic rationale and rigorous scientific data.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Amylyx Pharmaceuticals, Inc. (0001658551) (Filer) | 2026-05-07 | English | |
| 8-K - Amylyx Pharmaceuticals, Inc. (0001658551) (Filer) | 2026-05-07 | English | |
| ARS - Amylyx Pharmaceuticals, Inc. (0001658551) (Filer) | 2026-04-23 | English | |
| DEF 14A - Amylyx Pharmaceuticals, Inc. (0001658551) (Filer) | 2026-04-23 | English | |
| 8-K - Amylyx Pharmaceuticals, Inc. (0001658551) (Filer) | 2026-03-24 | English | |
| 4 - AMYLYX PHARMACEUTICALS, INC. (0001658551) (Filer) | 2026-03-04 | English |
Browse filings by year
12 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET A.Ş.
Specialty pharmaceutical firm for rare diseases and unmet m…
|
GENIL | TR | Manufacturing |
|
Genix Pharmaceuticals Corporation
Life sciences company specializing in generic drugs, nutrac…
|
GENX | CA | Manufacturing |
|
Genmab
Creates and develops antibody therapeutics for cancer and o…
|
GMAB | DK | Manufacturing |
|
Gennex Laboratories Ltd
Produces APIs and pharmaceutical intermediates for global h…
|
531739 | IN | Manufacturing |
|
GENOLUTION INC.
Develops molecular diagnostics and RNA interference solutio…
|
225220 | KR | Manufacturing |
|
Genome&Company
Develops microbiome drugs and novel immune checkpoint inhib…
|
314130 | KR | Manufacturing |
|
Genomma Lab Internacional, S.A.B. de C.V.
Develops, markets, and distributes OTC medications and pers…
|
LAB | MX | Manufacturing |
|
Genomtec S.A.
Develops mobile platforms for rapid, point-of-care molecula…
|
GMT | PL | Manufacturing |
|
Genor Biopharma Holdings Limited
Innovation-driven biopharma developing biological products …
|
6998 | KY | Manufacturing |
|
GENOTECH CORP.
Provides products and services for molecular biology resear…
|
066830 | KR | Manufacturing |
Amylyx Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31865/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31865 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31865 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31865 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31865}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Amylyx Pharmaceuticals, Inc. (id: 31865)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.